CAPSONI, SIMONA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.520
EU - Europa 11.979
AS - Asia 9.340
SA - Sud America 1.335
Continente sconosciuto - Info sul continente non disponibili 342
AF - Africa 221
OC - Oceania 16
Totale 41.753
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.199
IT - Italia 3.307
SG - Singapore 2.840
RU - Federazione Russa 2.468
CN - Cina 2.179
SE - Svezia 1.631
IE - Irlanda 1.262
KR - Corea 1.093
BR - Brasile 988
DE - Germania 925
TR - Turchia 758
VN - Vietnam 657
UA - Ucraina 627
HK - Hong Kong 576
GB - Regno Unito 488
FI - Finlandia 378
FR - Francia 272
BD - Bangladesh 247
IN - India 238
CA - Canada 180
CH - Svizzera 132
AR - Argentina 114
AT - Austria 102
JP - Giappone 95
IQ - Iraq 87
MX - Messico 73
NL - Olanda 69
ID - Indonesia 67
IL - Israele 67
PK - Pakistan 66
VE - Venezuela 66
ZA - Sudafrica 61
BE - Belgio 58
ES - Italia 58
PH - Filippine 56
PL - Polonia 55
SA - Arabia Saudita 54
EC - Ecuador 47
EU - Europa 47
CO - Colombia 45
UZ - Uzbekistan 45
MY - Malesia 32
AE - Emirati Arabi Uniti 29
MA - Marocco 29
CL - Cile 28
AL - Albania 26
EG - Egitto 26
TN - Tunisia 21
JM - Giamaica 20
KE - Kenya 19
JO - Giordania 17
LT - Lituania 17
PE - Perù 16
TW - Taiwan 16
PY - Paraguay 15
DZ - Algeria 14
CZ - Repubblica Ceca 13
TH - Thailandia 13
AU - Australia 12
RS - Serbia 12
AZ - Azerbaigian 11
LU - Lussemburgo 11
NP - Nepal 11
DK - Danimarca 10
ET - Etiopia 10
LB - Libano 10
PS - Palestinian Territory 10
CR - Costa Rica 9
KZ - Kazakistan 9
PT - Portogallo 9
HU - Ungheria 8
NI - Nicaragua 8
OM - Oman 8
BN - Brunei Darussalam 7
RO - Romania 7
UY - Uruguay 7
BO - Bolivia 6
PA - Panama 6
TT - Trinidad e Tobago 6
DO - Repubblica Dominicana 5
GE - Georgia 5
AO - Angola 4
BG - Bulgaria 4
BW - Botswana 4
HN - Honduras 4
IR - Iran 4
KG - Kirghizistan 4
LY - Libia 4
MD - Moldavia 4
MN - Mongolia 4
NG - Nigeria 4
SN - Senegal 4
XK - ???statistics.table.value.countryCode.XK??? 4
ZW - Zimbabwe 4
BH - Bahrain 3
BY - Bielorussia 3
KH - Cambogia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
SK - Slovacchia (Repubblica Slovacca) 3
Totale 41.395
Salva come PNG Salva come JPEG
Città #
Pisa 2.203
Ashburn 1.781
Dallas 1.699
Singapore 1.547
San Jose 1.389
Chandler 1.373
Jacksonville 1.307
Dublin 1.258
Seoul 1.083
Council Bluffs 1.050
Boardman 853
Moscow 575
Izmir 533
Wilmington 527
Hong Kong 521
Hefei 411
Ann Arbor 399
The Dalles 374
Boston 310
New York 282
Beijing 279
Clifton 277
Los Angeles 277
Millbury 264
Düsseldorf 227
Munich 215
Kent 192
Mestre 188
Ho Chi Minh City 183
San Mateo 181
Lauterbourg 170
Istanbul 164
Hanoi 155
Helsinki 140
Milan 132
Seattle 123
Ogden 121
Bremen 119
Santa Clara 109
Bern 107
Princeton 106
Washington 96
Lawrence 92
North Bergen 92
Vienna 91
Woodbridge 88
São Paulo 86
Chicago 85
Toronto 83
Frankfurt am Main 76
Tokyo 75
Buffalo 73
Orem 73
Guangzhou 69
Rome 67
San Paolo di Civitate 67
Saint Petersburg 63
Shanghai 60
Columbus 57
Dearborn 53
Turku 53
Brussels 51
Holon 51
Chennai 49
Atlanta 48
Warsaw 45
Denver 43
London 42
Montreal 41
Wuhan 41
Brooklyn 40
Dong Ket 39
Scuola 38
Da Nang 37
Amsterdam 36
Tashkent 36
Baghdad 35
Jakarta 34
Houston 32
Stockholm 32
Dhaka 28
Mexico City 28
Rio de Janeiro 28
San Giuliano Terme 28
Johannesburg 27
Belo Horizonte 26
Fairfield 26
Haiphong 26
Caracas 25
Las Vegas 25
San Francisco 25
Norwalk 23
Phoenix 23
Brasília 22
Nanjing 22
Manchester 21
Poplar 21
Florence 20
Jeddah 20
Lahore 20
Totale 25.957
Salva come PNG Salva come JPEG
Nome #
Initial events leading to ß amyloid expression in anti-NGF transgenic mice. 2.651
Graphene promotes axon elongation through local stall of Nerve Growth Factor signaling endosomes 521
2-Bromomelatonin: synthesis and characterization of a potent melatonin agonist 451
The contribution of early inflammation to neurodegeneration in anti-Nerve Growth Factor mice 398
Enteric Alpha-synuclein inclusions, colonic inflammation, increased mucosal permeability and alterations of Bowel neuromuscular functiond precede central neurodegeneration in a transgenic mouse model of Parkinson's disease 397
(2008) Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-ß-Mediated Cortical Synaptic Dysfunction 388
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor 386
A new mechanism for Alzheimer neurodegeneration: functional antagonism between proNGF, mature NGF and their receptors 340
NGF steers microglia toward a neuroprotective phenotype 333
Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons 325
A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model 319
Enteric alpha-synuclein accumulation impairs intestinal epithelial barrier through inflammasome activation before the onset of brain pathology in a transgenic mouse model of Parkinson's disease 311
Intranasal "painless" Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice 306
The positional identity of mouse ES cell-generated neurons is affected by BMP signaling. 304
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice 301
Congenital pain insensitivity mutation in nerve growth factor gene uncouples nociception from central features of pain in heterozygous humans and mice 297
A new generation of NGF-based therapy for Alzheimer’s disease 293
Amyloid plaque-independent deficit of early postnatal visual cortical plasticity in the 5xFAD transgenic model of Alzheimer's disease. 293
A small molecule targeting the multifactorial nature of Alzheimer's disease 292
The NGFR100W Mutation Specifically Impairs Nociception without Affecting Cognitive Performance in a Mouse Model of Hereditary Sensory and Autonomic Neuropathy Type V 288
Alzheimer-like neurodegeneration in anti-Nerve Growth Factor transgenic mice 285
A new generation of non invasive NGF-based therapies for Alzheimer’s Disease 281
Environmental enrichment prevents the onset of memory deficits and reduces neuropathological hallmarks in a mouse model of Alzheimer-like neurodegeneration 280
Abeta-Dependent Inhibition of LTP in Different Intra-Cortical Circuits of the Visual Cortex: The role of RAGE 278
Pathogen Free Conditions Slow the Onset of Neurodegeneration in a Mouse Model of Nerve Growth Factor Deprivation 278
A carnivore species (Canis familiaris) expresses circadian melatonin rhythm in the peripheral blood and melatonin receptors in the brain 278
COMPOSIZIONI IN GRADO DI PREVENIRE EVENTI NEURODEGENERATIVI E METODO PER SAGGIARNE L'ATTIVITA' 275
Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve-growth-factor mice 274
Alzheimer-like neurodegeneration in aged anti-nerve growth factor mice 267
Targeting the cation-chloride co-transporter NKCC1 to re-establish GABAergic inhibition and an appropriate excitatory/inhibitory balance in selective neuronal circuits: a novel approach for the treatment of Alzheimer's disease 257
ProNGFNGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice 254
Abeta (1-42) impairs LTP in mous eneocortex through RAGE mediated activation of p38 MAP kinase 254
A microglial function for the nerve growth factor : predictions of the unpredictable 253
Human TrkAR649W mutation impairs nociception, sweating and cognitive abilities : a mouse model of HSAN IV 252
ProNGF/NGF inbalance triggers neurodegeneration in transgenic mice. 252
Over-expression of furin-resistant pro-NGF determines neurodegeneration in transgenic mice 252
Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications 250
Identification of proNGF versus NGF expression fingerprinting in PC12 cells 249
Delivery of NGF to the Brain: Intranasal Versus Ocular Administration in Anti-NGF Transgenic Mice 249
Intranasal administration of a painless human NGF reduces memory deficit and amyloid oligomers accumulation in APPxPS1 mice 248
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson's disease before brain pathology 247
ANIMALI TRANSGENICI NON UMANI ANTI-NGF 246
MUTEINS OF HNGF, THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS 245
Alzheimer-like neurodegeneration in aged anti-Nerve Growth Factor (NGF) mice 239
An unbalance of proNGF/NGF signalling determines AD-like neurodegeneration in mice. 238
Environmental enrichment rescues visual memory deficits in a mouse model of Alzheimer disease 236
Effects of the cholinesterase inhibitor galantamine in a mouse model of Alzheimer's disease, the anti-nerve growth factor AD11 transgenic mice 233
Failure of nicotine-dependent enhancement of synaptic efficacy at Schaffer-collateral CA1 synapses of AD11 anti-nerve growth factor transgenic mice 231
Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: mining of microarray data by logic classification and feature selection 230
Effects of cholinesterase inhibitor galantamine in a mouse model of Alzheimer disease, the anti-NGF AD11 mice 230
Nerve Growth Factor regulates astrocyte physiology in vivo 230
Reversal of neurological deficits by painless nerve growth factor in a mouse model of Rett syndrome 229
Ganstigmine and donepezil improve neurodegeneration in AD11 antinerve growth factor transgenic mice 229
IN VITRO RECEPTOR BINDING PROPERTIES OF A "PAINLESS" NGF MUTEIN, LINKED TO HEREDITARY SENSORY AUTONOMIC NEUROPATHY TYPE V 226
Role of NGF in modulating adult neurogenesis in ALzheimer's disease mouse model 226
Intranasal administration of an optimized human Nerve Growth Factor reduces memory deficits and amyloid oligomers accumulation in APPxPS1 mice 223
Development of a non-invasive NGF-based therapy for Alzheimer's disease. Current Alzheimer Research 6: 158 222
Reduced levels of NGF shift astrocytes toward a neurotoxic phenotype 221
Amelioration of the neurodegenerative phenotype in AD11 anti-NGF mice 219
Autoradiographic localization of putative melatonin receptors in the brains of two old world primates: Cercopithecus aethiops and Papio ursinus 218
ProNGF Drives Localized and Cell Selective Parvalbumin Interneuron and Perineuronal Net Depletion in the Dentate Gyrus of Transgenic Mice 218
Transgenic mice with chronic NGF deprivation and Alzheimer's disease-like pathology display hippocampal region-specific impairments in short- and long-term plasticities 217
Nerve Growth Factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice 213
Involvement of NGF in early stages of chick embryo development 213
Localization and characterization of melatonin binding sites in the brain of the rabbit (Oryctolagus cuniculus) by autoradiography and in vitro ligand-receptor binding 213
Intranasal delivery of therapeutic proteins for neurological diseases 213
Delivery of NGF to the brain: intranasal versus ocular administration in anti-NGF transgenic mice. J Alzheimers Dis 16: 371 213
On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer’s disease 212
The role of Nerve Growth Factor in development and in ALzheimer's disease 208
Taking pain out of NGF: a "painless" NGF mutant, linked to hereditary sensory autonomic neuropathy type V, with full neurotrophic activity. 208
Role of NGF in modulating adult neurogenesis in an Alzheimer's disease mouse model 206
Rat visual cortical neurones express TrkA NGF receptor 203
From genes to pain: nerve growth factor and hereditary sensory and autonomic neuropathy type V 201
PHENOTYPIC KNOCKOUT OF NERVE GROWTH FACTOR IN ADULT TRANSGENIC MICE REVEALS SEVERE DEFICITS IN BASAL FOREBRAIN CHOLINERGIC NEURONS, CELL DEATH IN THE SPLEEN, AND SKELETAL MUSCLE DYSTROPHY 200
Neutralization of nerve growth factor impairs proliferation and differentiation of adult neural progenitors in the subventricular zone 200
Nerve growth factor regulates axial rotation during early stages of chick embryo development 195
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 195
Memoquin: a new compound to attack Alzheimer disease on multiple fronts 195
Memoquin: A new therapeutic poly-agent for Alzheimer's disease 192
Peripheral Neutralization of Nerve Growth Factor Induces Immunosympathectomy and Central Neurodegeneration in Transgenic Mice 191
Interaction between NH2-tau fragment and Aß in AD mitochondria contributes to the synaptic deterioration 191
Long-term memantine treatment prevents behavioral deficits in a mouse model of sporadic Alzheimer's disease 190
Understanding pain perception through genetic painlessness diseases : the role of NGF and proNGF 189
BDNF intranasal administration rescues visual memory deficits in a mouse model of Alzheimer disease (AD), the AD11 mouse 188
Intranasal delivery of BDNF rescues memory deficits in AD11 mice and reduces brain microgliosis 188
Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer's disease models 186
Environmental enrichment rescues visual memory deficits in a mouse model of Alzheimer disease after the onset of neurodegeneration 185
Long-term memantine treatment prevents behaviour deficits in a mouse model of sporadic Alzheimer's disease 185
Postnatal development of GFAP in mouse visual cortex is not affected by light deprivation 185
COMPOSITIONS ABLE TO PREVENT NEURODEGENERATIVE PROCESSES AND METHODS OF ASSAYING THE SAME 185
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 183
Early involvement of inflammation and immune response mRNAs in the brain of anti-Nerve Growth Factor AD11 mice, as revealed by gene expression profiling 183
Autoradiographic quantification of endothelin ET(A)receptors in peripheral and brain arteries of the rat 182
Expression of the melatonin receptors in Xenopus laevis 182
Nerve growth factor neutralization promotes oligodendrogenesis by increasing miR-219a-5p levels 180
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 180
Antagonization of NGF in adult mice by transgenic antibodies causes progressive learning and memory impairments 179
Time window in cholinomimetic ability to rescue long-term potentiation in neurodegenerating anti-nerve growth factor mice 179
The richness of the environment bidirectionally affects the progression of the disease in a mous emodel of Alzheimer's disease, the AD11 mice 179
Muscular dystrophy in adult and aged anti-NGF transgenic mice resembles an inclusion body myopathy 179
Totale 26.862
Salva come PNG Salva come JPEG
Categoria #
all - tutte 200.498
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 200.498
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.329 0 14 11 78 99 19 31 127 92 76 71 711
2022/20236.174 413 377 260 427 382 599 4 1.562 1.850 33 124 143
2023/20241.912 268 47 215 47 137 388 72 104 207 72 10 345
2024/20258.711 1.664 292 268 738 899 180 589 334 1.255 426 978 1.088
2025/202615.850 928 1.432 2.155 1.426 1.025 656 2.643 951 2.181 1.129 715 609
2026/20271.157 718 439 0 0 0 0 0 0 0 0 0 0
Totale 41.753